OP
PTLA

Omni Partners’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Omni Partners’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,213,440
Closed -$57.8M – 147
2020
Q2 		$57.8M Buy
+3,213,440
New +$44.7M 6.83% 5

Omni Partners's PTLA Position: Q3 2020 in Review

Omni Partners sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 3,213,440 shares — an estimated $57.8M sold.

Omni Partners first reported a position in PTLA in Q2 2020 and held it in 1 quarter. The position peaked at $57.8M in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • Omni Partners reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Omni Partners sold 3,213,440 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $57.8M.
  • Omni Partners first reported a position in Portola Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
  • Omni Partners's Portola Pharmaceuticals, Inc. position peaked at $57.8M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Omni Partners's 13F filing for Q3 2020, filed 13 Nov 2020.